Aller au contenu
Global sound
Lung Cancer Considered

Lung Cancer Considered

ESMO 2026 Highlights – Part 1

· 1 h 26 min

Notes d’épisode

In this episode of Lung Cancer Considered, Drs. Jacob Sands, Ferdinandos Skoulidis, and Jarushka Naidoo discuss key research highlights from ESMO 2026, including results from the DeLLphi-305 trial evaluating tarlatamab in extensive-stage small cell lung cancer and the KRAScendo-1 trial investigating divarasib in KRAS G12C-mutated NSCLC. The discussion also explores emerging immunotherapy strategies, including findings from the MOIO and OptiTROP-Lung06 studies, advances in predicting immune-related toxicities, and the potential implications of these developments for clinical practice.

Jaruska Naidoo, MD
Professor of Medical Oncology
Royal College of Surgeons
Consultant, Medical Oncologist at Beaumont Hospital
X: @DrJNaidoo
Instagram: jarushkanaidoo
LinkedIn: https://www.linkedin.com/in/jarushka-naidoo-127a3b97/

Jacob Sands, MD
Assistant Professor of Medicine, Harvard Medical School
Associate Chief, Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
X: @sands_jacob
Instagram: jacobsands
LinkedIn: https://www.linkedin.com/in/jacobsands/

Ferdinandos Skoulidis, MD, PhD
Professor, Department of Thoracic and Head and Neck Medical Oncology
University of Texas MD Anderson Cancer Center

Site web: soundcloud.com

En direct, dernière heure : 8 762 titres sur 4 745 stations dans 122 pays

Découvrez le monde par la radio

Plus de façons de découvrir (7)

Vous avez entendu quelque chose de bien ? Enregistrez-le, ou ouvrez-le directement dans Spotify.

★ Artiste de la semaine La plus forte progression à la radio cette semaine
Ton titre ici ? À partir de € 9 par semaine →
WEHA 88.7 FM Continuer l’écoute